ArticleClinical and molecular hepatology2024

Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma.

Yu-Hang Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.